ID   PP1A_HUMAN              Reviewed;         330 AA.
AC   P62136; A6NNR3; B2R908; P08129; P20653; P22802; Q07161;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2004, sequence version 1.
DT   22-JUL-2015, entry version 130.
DE   RecName: Full=Serine/threonine-protein phosphatase PP1-alpha catalytic subunit;
DE            Short=PP-1A;
DE            EC=3.1.3.16;
GN   Name=PPP1CA; Synonyms=PPP1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=8392016; DOI=10.1016/0378-1119(93)90282-8;
RA   Song Q., Khanna K.K., Lu H., Lavin M.F.;
RT   "Cloning and characterization of a human protein phosphatase 1-
RT   encoding cDNA.";
RL   Gene 129:291-295(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=8384581; DOI=10.1101/gad.7.4.555;
RA   Durfee T., Becherer K., Chen P.L., Yeh S.H., Yang Y., Kilburn A.E.,
RA   Lee W.H., Elledge S.J.;
RT   "The retinoblastoma protein associates with the protein phosphatase
RT   type 1 catalytic subunit.";
RL   Genes Dev. 7:555-569(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Tung L.;
RL   Submitted (APR-1991) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle, Pancreas, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-15 AND 247-261, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 23-330 (ISOFORM 1).
RX   PubMed=2161401; DOI=10.1016/0888-7543(90)90536-4;
RA   Barker H.M., Jones T.A., da Cruz e Silva E.F., Spurr N.K., Sheer D.,
RA   Cohen P.T.W.;
RT   "Localization of the gene encoding a type I protein phosphatase
RT   catalytic subunit to human chromosome band 11q13.";
RL   Genomics 7:159-166(1990).
RN   [10]
RP   INTERACTION WITH PPP1R15A AND HHV-1 ICP34.5.
RX   PubMed=9023344; DOI=10.1073/pnas.94.3.843;
RA   He B., Gross M., Roizman B.;
RT   "The gamma(1)34.5 protein of herpes simplex virus 1 complexes with
RT   protein phosphatase 1alpha to dephosphorylate the alpha subunit of the
RT   eukaryotic translation initiation factor 2 and preclude the shutoff of
RT   protein synthesis by double-stranded RNA-activated protein kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:843-848(1997).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PPP1R8.
RX   PubMed=11739654;
RA   Trinkle-Mulcahy L., Sleeman J.E., Lamond A.I.;
RT   "Dynamic targeting of protein phosphatase 1 within the nuclei of
RT   living mammalian cells.";
RL   J. Cell Sci. 114:4219-4228(2001).
RN   [12]
RP   INTERACTION WITH PPP1R15A.
RX   PubMed=11564868; DOI=10.1128/MCB.21.20.6841-6850.2001;
RA   Connor J.H., Weiser D.C., Li S., Hallenbeck J.M., Shenolikar S.;
RT   "Growth arrest and DNA damage-inducible protein GADD34 assembles a
RT   novel signaling complex containing protein phosphatase 1 and inhibitor
RT   1.";
RL   Mol. Cell. Biol. 21:6841-6850(2001).
RN   [13]
RP   INTERACTION WITH PPP1R7.
RX   PubMed=12226088; DOI=10.1074/jbc.M206838200;
RA   Ceulemans H., Vulsteke V., De Maeyer M., Tatchell K., Stalmans W.,
RA   Bollen M.;
RT   "Binding of the concave surface of the Sds22 superhelix to the alpha
RT   4/alpha 5/alpha 6-triangle of protein phosphatase-1.";
RL   J. Biol. Chem. 277:47331-47337(2002).
RN   [14]
RP   REVIEW.
RX   PubMed=11839776;
RA   Cohen P.T.W.;
RT   "Protein phosphatase 1 -- targeted in many directions.";
RL   J. Cell Sci. 115:241-256(2002).
RN   [15]
RP   INTERACTION WITH PPP1R16B AND RPSA.
RX   PubMed=16263087; DOI=10.1016/j.bbrc.2005.10.089;
RA   Kim K., Li L., Kozlowski K., Suh H.S., Cao W., Ballermann B.J.;
RT   "The protein phosphatase-1 targeting subunit TIMAP regulates LAMR1
RT   phosphorylation.";
RL   Biochem. Biophys. Res. Commun. 338:1327-1334(2005).
RN   [16]
RP   ENZYME REGULATION.
RX   PubMed=15705855; DOI=10.1126/science.1101902;
RA   Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D.,
RA   Kaufman R.J., Ma D., Coen D.M., Ron D., Yuan J.;
RT   "A selective inhibitor of eIF2alpha dephosphorylation protects cells
RT   from ER stress.";
RL   Science 307:935-939(2005).
RN   [17]
RP   INTERACTION WITH FER, AND PHOSPHORYLATION AT THR-320.
RX   PubMed=16732323; DOI=10.1038/sj.onc.1209695;
RA   Pasder O., Shpungin S., Salem Y., Makovsky A., Vilchick S.,
RA   Michaeli S., Malovani H., Nir U.;
RT   "Downregulation of Fer induces PP1 activation and cell-cycle arrest in
RT   malignant cells.";
RL   Oncogene 25:4194-4206(2006).
RN   [18]
RP   IDENTIFICATION IN A COMPLEX WITH ILF2; ILF3; YLPM1; KHDRBS1; RBMX AND
RP   NCOA5, AND INTERACTION WITH YLPM1.
RX   PubMed=17890166; DOI=10.1016/j.bbapap.2007.07.015;
RA   Ulke-Lemee A., Trinkle-Mulcahy L., Chaulk S., Bernstein N.K.,
RA   Morrice N., Glover M., Lamond A.I., Moorhead G.B.G.;
RT   "The nuclear PP1 interacting protein ZAP3 (ZAP) is a putative
RT   nucleoside kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-
RT   G.";
RL   Biochim. Biophys. Acta 1774:1339-1350(2007).
RN   [19]
RP   FUNCTION, INTERACTION WITH NEK2, AND DEPHOSPHORYLATION.
RX   PubMed=17283141; DOI=10.1158/0008-5472.CAN-06-3071;
RA   Mi J., Guo C., Brautigan D.L., Larner J.M.;
RT   "Protein phosphatase-1alpha regulates centrosome splitting through
RT   Nek2.";
RL   Cancer Res. 67:1082-1089(2007).
RN   [20]
RP   INTERACTION WITH NEK2.
RX   PubMed=17626005; DOI=10.1074/jbc.M704969200;
RA   Wu W., Baxter J.E., Wattam S.L., Hayward D.G., Fardilha M., Knebel A.,
RA   Ford E.M., da Cruz e Silva E.F., Fry A.M.;
RT   "Alternative splicing controls nuclear translocation of the cell
RT   cycle-regulated Nek2 kinase.";
RL   J. Biol. Chem. 282:26431-26440(2007).
RN   [21]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH NOM1.
RX   PubMed=17965019; DOI=10.1074/jbc.M706708200;
RA   Gunawardena S.R., Ruis B.L., Meyer J.A., Kapoor M., Conklin K.F.;
RT   "NOM1 targets protein phosphatase I to the nucleolus.";
RL   J. Biol. Chem. 283:398-404(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   IDENTIFICATION IN THE MLL5-L COMPLEX.
RX   PubMed=19377461; DOI=10.1038/nature07954;
RA   Fujiki R., Chikanishi T., Hashiba W., Ito H., Takada I., Roeder R.G.,
RA   Kitagawa H., Kato S.;
RT   "GlcNAcylation of a histone methyltransferase in retinoic-acid-induced
RT   granulopoiesis.";
RL   Nature 459:455-459(2009).
RN   [25]
RP   INTERACTION WITH DAB2.
RX   PubMed=19581931; DOI=10.1038/onc.2009.157;
RA   Jiang Y., Luo W., Howe P.H.;
RT   "Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by
RT   preventing protein phosphatase 1 (PP1)-Axin interactions.";
RL   Oncogene 28:2999-3007(2009).
RN   [26]
RP   IDENTIFICATION IN THE PTW/PP1 PHOSPHATASE COMPLEX, AND INTERACTION
RP   WITH WDR82; PPP1R8 AND PPP1R10/PNUTS.
RX   PubMed=20516061; DOI=10.1074/jbc.M110.109801;
RA   Lee J.H., You J., Dobrota E., Skalnik D.G.;
RT   "Identification and characterization of a novel human PP1 phosphatase
RT   complex.";
RL   J. Biol. Chem. 285:24466-24476(2010).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [28]
RP   INTERACTION WITH TRIM28.
RX   PubMed=20424263; DOI=10.1126/scisignal.2000781;
RA   Li X., Lin H.H., Chen H., Xu X., Shih H.M., Ann D.K.;
RT   "SUMOylation of the transcriptional co-repressor KAP1 is regulated by
RT   the serine and threonine phosphatase PP1.";
RL   Sci. Signal. 3:RA32-RA32(2010).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [30]
RP   FUNCTION IN CIRCADIAN CLOCK.
RX   PubMed=21712997; DOI=10.1371/journal.pone.0021325;
RA   Schmutz I., Wendt S., Schnell A., Kramer A., Mansuy I.M., Albrecht U.;
RT   "Protein phosphatase 1 (PP1) is a post-translational regulator of the
RT   mammalian circadian clock.";
RL   PLoS ONE 6:E21325-E21325(2011).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [32]
RP   FUNCTION, INTERACTION WITH FOXP3, AND INDUCTION.
RX   PubMed=23396208; DOI=10.1038/nm.3085;
RA   Nie H., Zheng Y., Li R., Guo T.B., He D., Fang L., Liu X., Xiao L.,
RA   Chen X., Wan B., Chin Y.E., Zhang J.Z.;
RT   "Phosphorylation of FOXP3 controls regulatory T cell function and is
RT   inhibited by TNF-alpha in rheumatoid arthritis.";
RL   Nat. Med. 19:322-328(2013).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (1.63 ANGSTROMS) OF 7-300 IN COMPLEX WITH
RP   INHIBITORS, COFACTOR, MANGANESE-BINDING SITES, AND SUBUNIT.
RX   PubMed=18992256; DOI=10.1016/j.jmb.2008.10.053;
RA   Kelker M.S., Page R., Peti W.;
RT   "Crystal structures of protein phosphatase-1 bound to nodularin-R and
RT   tautomycin: a novel scaffold for structure-based drug design of
RT   serine/threonine phosphatase inhibitors.";
RL   J. Mol. Biol. 385:11-21(2009).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 7-330 IN COMPLEX WITH RAT
RP   PPP1R9A AND PPP1R9B.
RX   PubMed=20305656; DOI=10.1038/nsmb.1786;
RA   Ragusa M.J., Dancheck B., Critton D.A., Nairn A.C., Page R., Peti W.;
RT   "Spinophilin directs protein phosphatase 1 specificity by blocking
RT   substrate binding sites.";
RL   Nat. Struct. Mol. Biol. 17:459-464(2010).
CC   -!- FUNCTION: Protein phosphatase that associates with over 200
CC       regulatory proteins to form highly specific holoenzymes which
CC       dephosphorylate hundreds of biological targets. Protein
CC       phosphatase 1 (PP1) is essential for cell division, and
CC       participates in the regulation of glycogen metabolism, muscle
CC       contractility and protein synthesis. Involved in regulation of
CC       ionic conductances and long-term synaptic plasticity. May play an
CC       important role in dephosphorylating substrates such as the
CC       postsynaptic density-associated Ca(2+)/calmodulin dependent
CC       protein kinase II. Component of the PTW/PP1 phosphatase complex,
CC       which plays a role in the control of chromatin structure and cell
CC       cycle progression during the transition from mitosis into
CC       interphase. Regulates NEK2 function in terms of kinase activity
CC       and centrosome number and splitting, both in the presence and
CC       absence of radiation-induced DNA damage. Regulator of neural tube
CC       and optic fissure closure, and enteric neural crest cell (ENCCs)
CC       migration during development. In balance with CSNK1D and CSNK1E,
CC       determines the circadian period length, through the regulation of
CC       the speed and rhythmicity of PER1 and PER2 phosphorylation. May
CC       dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418'
CC       residue of FOXP3 in regulatory T-cells (Treg) from patients with
CC       rheumatoid arthritis, thereby inactivating FOXP3 and rendering
CC       Treg cells functionally defective (PubMed:23396208).
CC       {ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:21712997,
CC       ECO:0000269|PubMed:23396208}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000250};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:18992256};
CC       Note=Binds 2 manganese ions per subunit.
CC       {ECO:0000269|PubMed:18992256};
CC   -!- ENZYME REGULATION: The phosphatase activity of the PPP1R15A-PP1
CC       complex toward EIF2S1 is specifically inhibited by Salubrinal, a
CC       drug that protects cells from endoplasmic reticulum stress.
CC       {ECO:0000269|PubMed:15705855}.
CC   -!- SUBUNIT: PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or
CC       PPP1CC, which is folded into its native form by inhibitor 2 and
CC       glycogen synthetase kinase 3, and then complexed to one or several
CC       targeting or regulatory subunits. PPP1R12A, PPP1R12B and PPP1R12C
CC       mediate binding to myosin. PPP1R3A (in skeletal muscle), PPP1R3B
CC       (in liver), PPP1R3C, PPP1R3D and PPP1R3F (in brain) mediate
CC       binding to glycogen. Interacts with PPP1R39 (By similarity).
CC       Interacts with BTBD10 (By similarity). Interacts with KCTD20 (By
CC       similarity)Interacts with PPP1R9A and PPP1R9B. Part of a complex
CC       containing PPP1R15B, PP1 and NCK1/2. Interacts with PHACTR4; which
CC       acts as an activator of PP1 activity (By similarity). Interacts
CC       with PPP1R15A and PPP1R15B; the interactions mediate binding to
CC       EIF2S1. Component of the MLL5-L complex, at least composed of
CC       KMT2E/MLL5, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT.
CC       Interacts with PPP1R7. Interacts with YLPM1. Forms a complex with
CC       ILF2, ILF3, YLPM1, KHDRBS1, RBMX and NCOA5. Interacts with NOM1
CC       and PPP1R8. Interacts with HHV-1 ICP34.5. Interacts with PPP1R16B.
CC       Interacts with RPSA only in the presence of PPP1R16B. Component of
CC       the PTW/PP1 phosphatase complex, composed of PPP1R10/PNUTS, TOX4,
CC       WDR82, and PPP1CA or PPP1CB or PPP1CC. Interacts with
CC       PPP1R10/PNUTS and PPP1R8. Interacts with WDR82 in the presence of
CC       PPP1R10/PNUTS. Interacts with TRIM28; the interaction
CC       dephosphorylates TRIM28 on 'Ser-824' and forms a complex at the
CC       p21 promoter site. Interacts with isoform 1 and isoform 4 of NEK2.
CC       Interacts with FER; this promotes phosphorylation at Thr-320.
CC       Interacts with DAB2; the interaction is mutually exclusive with
CC       the AXIN1:PPP1CA interaction. Interacts with FOXP3.
CC       {ECO:0000250|UniProtKB:P62137, ECO:0000250|UniProtKB:P62139,
CC       ECO:0000269|PubMed:11564868, ECO:0000269|PubMed:11739654,
CC       ECO:0000269|PubMed:12226088, ECO:0000269|PubMed:16263087,
CC       ECO:0000269|PubMed:16732323, ECO:0000269|PubMed:17283141,
CC       ECO:0000269|PubMed:17626005, ECO:0000269|PubMed:17890166,
CC       ECO:0000269|PubMed:17965019, ECO:0000269|PubMed:18992256,
CC       ECO:0000269|PubMed:19377461, ECO:0000269|PubMed:19581931,
CC       ECO:0000269|PubMed:20305656, ECO:0000269|PubMed:20424263,
CC       ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:23396208,
CC       ECO:0000269|PubMed:9023344}.
CC   -!- INTERACTION:
CC       P31749:AKT1; NbExp=6; IntAct=EBI-357253, EBI-296087;
CC       O14727:APAF1; NbExp=2; IntAct=EBI-357253, EBI-446492;
CC       O15169:AXIN1; NbExp=4; IntAct=EBI-357253, EBI-710484;
CC       P38398:BRCA1; NbExp=2; IntAct=EBI-357253, EBI-349905;
CC       Q8NG31:CASC5; NbExp=2; IntAct=EBI-357253, EBI-1001161;
CC       O95400:CD2BP2; NbExp=2; IntAct=EBI-357253, EBI-768015;
CC       P12830:CDH1; NbExp=2; IntAct=EBI-357253, EBI-727477;
CC       Q8TEP8:CEP192; NbExp=2; IntAct=EBI-357253, EBI-2339778;
CC       Q9NX63:CHCHD3; NbExp=2; IntAct=EBI-357253, EBI-743375;
CC       O08785:Clock (xeno); NbExp=2; IntAct=EBI-357253, EBI-79859;
CC       Q6PJW8:CNST; NbExp=3; IntAct=EBI-357253, EBI-750390;
CC       Q96S65:CSRNP1; NbExp=4; IntAct=EBI-357253, EBI-4311573;
CC       Q9H175:CSRNP2; NbExp=6; IntAct=EBI-357253, EBI-5235958;
CC       Q92796:DLG3; NbExp=2; IntAct=EBI-357253, EBI-80440;
CC       P55199:ELL; NbExp=2; IntAct=EBI-357253, EBI-1245868;
CC       Q5S007:LRRK2; NbExp=6; IntAct=EBI-357253, EBI-5323863;
CC       O00566:MPHOSPH10; NbExp=2; IntAct=EBI-357253, EBI-5235884;
CC       Q96KQ4:PPP1R13B; NbExp=5; IntAct=EBI-357253, EBI-1105153;
CC       Q8WUF5:PPP1R13L; NbExp=4; IntAct=EBI-357253, EBI-5550163;
CC       Q5SWA1:PPP1R15B; NbExp=3; IntAct=EBI-357253, EBI-2815482;
CC       P41236:PPP1R2; NbExp=2; IntAct=EBI-357253, EBI-1056517;
CC       Q5T8A7:PPP1R26; NbExp=2; IntAct=EBI-357253, EBI-308500;
CC       Q86WC6:PPP1R27; NbExp=2; IntAct=EBI-357253, EBI-5235602;
CC       Q6NXS1:PPP1R2P3; NbExp=3; IntAct=EBI-357253, EBI-10251630;
CC       Q7Z5V6:PPP1R32; NbExp=3; IntAct=EBI-357253, EBI-4311771;
CC       O75864:PPP1R37; NbExp=2; IntAct=EBI-357253, EBI-5235692;
CC       Q12972:PPP1R8; NbExp=3; IntAct=EBI-357253, EBI-716633;
CC       Q96SB3:PPP1R9B; NbExp=5; IntAct=EBI-357253, EBI-351275;
CC       P60484:PTEN; NbExp=2; IntAct=EBI-357253, EBI-696162;
CC       P06400:RB1; NbExp=2; IntAct=EBI-357253, EBI-491274;
CC       P36313:RL1 (xeno); NbExp=4; IntAct=EBI-357253, EBI-6149234;
CC       A8K8P3:SFI1; NbExp=2; IntAct=EBI-357253, EBI-743371;
CC       Q562F6:SGOL2; NbExp=4; IntAct=EBI-357253, EBI-989213;
CC       Q9H788:SH2D4A; NbExp=2; IntAct=EBI-357253, EBI-747035;
CC       Q8TEC5:SH3RF2; NbExp=3; IntAct=EBI-357253, EBI-2130111;
CC       P63208:SKP1; NbExp=3; IntAct=EBI-357253, EBI-307486;
CC       Q7Z699:SPRED1; NbExp=4; IntAct=EBI-357253, EBI-5235340;
CC       Q9HCH5:SYTL2; NbExp=2; IntAct=EBI-357253, EBI-2690103;
CC       Q14C87:TMEM132D; NbExp=2; IntAct=EBI-357253, EBI-5235567;
CC       Q13625:TP53BP2; NbExp=7; IntAct=EBI-357253, EBI-77642;
CC       Q8TEL6:TRPC4AP; NbExp=2; IntAct=EBI-357253, EBI-2559060;
CC       P49815:TSC2; NbExp=2; IntAct=EBI-357253, EBI-396587;
CC       Q9H4A3:WNK1; NbExp=2; IntAct=EBI-357253, EBI-457907;
CC       Q9HBF4:ZFYVE1; NbExp=2; IntAct=EBI-357253, EBI-4401611;
CC       O95405:ZFYVE9; NbExp=3; IntAct=EBI-357253, EBI-296817;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Nucleus, nucleoplasm.
CC       Nucleus, nucleolus. Note=Primarily nuclear and largely excluded
CC       from the nucleolus. Highly mobile in cells and can be relocalized
CC       through interaction with targeting subunits. NOM1 plays a role in
CC       targeting this protein to the nucleolus. In the presence of PPP1R8
CC       relocalizes from the nucleus to nuclear speckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P62136-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P62136-2; Sequence=VSP_043377;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P62136-3; Sequence=VSP_046754;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- INDUCTION: Up-regulated in synovial fluid mononuclear cells and
CC       peripheral blood mononuclear cells from patients with rheumatoid
CC       arthritis. {ECO:0000269|PubMed:23396208}.
CC   -!- PTM: Phosphorylated. Dephosphorylated at Thr-320 in the presence
CC       of ionizing radiation. {ECO:0000269|PubMed:16732323}.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The things we forget -
CC       Issue 32 of March 2003;
CC       URL="http://web.expasy.org/spotlight/back_issues/032";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X70848; CAA50197.1; -; mRNA.
DR   EMBL; S57501; AAB26015.1; -; mRNA.
DR   EMBL; M63960; AAA36508.1; -; mRNA.
DR   EMBL; AK313586; BAG36355.1; -; mRNA.
DR   EMBL; BT006629; AAP35275.1; -; mRNA.
DR   EMBL; AP003419; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001888; AAH01888.1; -; mRNA.
DR   EMBL; BC004482; AAH04482.1; -; mRNA.
DR   EMBL; BC008010; AAH08010.1; -; mRNA.
DR   EMBL; J04759; AAA36475.1; -; mRNA.
DR   CCDS; CCDS31618.1; -. [P62136-2]
DR   CCDS; CCDS8160.1; -. [P62136-1]
DR   CCDS; CCDS8161.1; -. [P62136-3]
DR   RefSeq; NP_001008709.1; NM_001008709.1. [P62136-2]
DR   RefSeq; NP_002699.1; NM_002708.3. [P62136-1]
DR   RefSeq; NP_996756.1; NM_206873.1. [P62136-3]
DR   UniGene; Hs.183994; -.
DR   PDB; 3E7A; X-ray; 1.63 A; A/B=7-300.
DR   PDB; 3E7B; X-ray; 1.70 A; A/B=7-300.
DR   PDB; 3EGG; X-ray; 1.85 A; A/B=7-330.
DR   PDB; 3EGH; X-ray; 2.00 A; A/B=7-330.
DR   PDB; 3HVQ; X-ray; 2.20 A; A/B=7-330.
DR   PDB; 3N5U; X-ray; 3.20 A; A/B=1-300.
DR   PDB; 3V4Y; X-ray; 2.10 A; A/C/E/G=7-307.
DR   PDB; 4G9J; X-ray; 3.10 A; A/B=1-330.
DR   PDB; 4MOV; X-ray; 1.45 A; A/B=7-300.
DR   PDB; 4MOY; X-ray; 2.20 A; A=7-300.
DR   PDB; 4MP0; X-ray; 2.10 A; A/C=7-300.
DR   PDBsum; 3E7A; -.
DR   PDBsum; 3E7B; -.
DR   PDBsum; 3EGG; -.
DR   PDBsum; 3EGH; -.
DR   PDBsum; 3HVQ; -.
DR   PDBsum; 3N5U; -.
DR   PDBsum; 3V4Y; -.
DR   PDBsum; 4G9J; -.
DR   PDBsum; 4MOV; -.
DR   PDBsum; 4MOY; -.
DR   PDBsum; 4MP0; -.
DR   ProteinModelPortal; P62136; -.
DR   SMR; P62136; 7-299.
DR   BioGrid; 111493; 259.
DR   DIP; DIP-221N; -.
DR   DIP; DIP-38195N; -.
DR   IntAct; P62136; 220.
DR   MINT; MINT-5001223; -.
DR   STRING; 9606.ENSP00000326031; -.
DR   BindingDB; P62136; -.
DR   ChEMBL; CHEMBL2164; -.
DR   DEPOD; P62136; -.
DR   PhosphoSite; P62136; -.
DR   BioMuta; PPP1CA; -.
DR   DMDM; 49065811; -.
DR   OGP; P08129; -.
DR   MaxQB; P62136; -.
DR   PaxDb; P62136; -.
DR   PRIDE; P62136; -.
DR   DNASU; 5499; -.
DR   Ensembl; ENST00000312989; ENSP00000326031; ENSG00000172531. [P62136-2]
DR   Ensembl; ENST00000358239; ENSP00000350974; ENSG00000172531. [P62136-3]
DR   Ensembl; ENST00000376745; ENSP00000365936; ENSG00000172531.
DR   GeneID; 5499; -.
DR   KEGG; hsa:5499; -.
DR   UCSC; uc001oku.1; human. [P62136-2]
DR   UCSC; uc001okw.1; human. [P62136-1]
DR   CTD; 5499; -.
DR   GeneCards; GC11M067165; -.
DR   HGNC; HGNC:9281; PPP1CA.
DR   HPA; CAB004545; -.
DR   HPA; HPA046833; -.
DR   MIM; 176875; gene.
DR   neXtProt; NX_P62136; -.
DR   PharmGKB; PA33609; -.
DR   eggNOG; COG0639; -.
DR   GeneTree; ENSGT00530000062911; -.
DR   HOGENOM; HOG000172697; -.
DR   HOVERGEN; HBG000216; -.
DR   InParanoid; P62136; -.
DR   KO; K06269; -.
DR   OMA; QGLETIC; -.
DR   OrthoDB; EOG7TJ3K3; -.
DR   PhylomeDB; P62136; -.
DR   TreeFam; TF354243; -.
DR   BRENDA; 3.1.3.16; 2681.
DR   Reactome; REACT_120727; Downregulation of TGF-beta receptor signaling.
DR   Reactome; REACT_15334; DARPP-32 events.
DR   Reactome; REACT_24941; Circadian Clock.
DR   Reactome; REACT_494; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   SignaLink; P62136; -.
DR   ChiTaRS; PPP1CA; human.
DR   EvolutionaryTrace; P62136; -.
DR   GeneWiki; PPP1CA; -.
DR   GenomeRNAi; 5499; -.
DR   NextBio; 21272; -.
DR   PRO; PR:P62136; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; P62136; -.
DR   CleanEx; HS_PPP1CA; -.
DR   ExpressionAtlas; P62136; baseline and differential.
DR   Genevisible; P62136; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0042587; C:glycogen granule; IEA:Ensembl.
DR   GO; GO:0070688; C:MLL5-L complex; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000164; C:protein phosphatase type 1 complex; IEA:Ensembl.
DR   GO; GO:0072357; C:PTW/PP1 phosphatase complex; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016791; F:phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0016311; P:dephosphorylation; IDA:CACAO.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0005979; P:regulation of glycogen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0005981; P:regulation of glycogen catabolic process; IEA:Ensembl.
DR   GO; GO:0036496; P:regulation of translational initiation by eIF2 alpha dephosphorylation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019433; P:triglyceride catabolic process; TAS:Reactome.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_apaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Carbohydrate metabolism; Cell cycle; Cell division; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Glycogen metabolism; Hydrolase;
KW   Manganese; Metal-binding; Nucleus; Phosphoprotein;
KW   Protein phosphatase; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:22814378,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    330       Serine/threonine-protein phosphatase PP1-
FT                                alpha catalytic subunit.
FT                                /FTId=PRO_0000058774.
FT   ACT_SITE    125    125       Proton donor. {ECO:0000250}.
FT   METAL        64     64       Manganese 1. {ECO:0000250}.
FT   METAL        66     66       Manganese 1. {ECO:0000250}.
FT   METAL        92     92       Manganese.
FT   METAL        92     92       Manganese 1. {ECO:0000250}.
FT   METAL        92     92       Manganese 2. {ECO:0000250}.
FT   METAL       124    124       Manganese.
FT   METAL       124    124       Manganese 2. {ECO:0000250}.
FT   METAL       173    173       Manganese.
FT   METAL       173    173       Manganese 2. {ECO:0000250}.
FT   METAL       248    248       Manganese.
FT   METAL       248    248       Manganese 2. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000269|PubMed:22814378,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     305    305       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P62137}.
FT   MOD_RES     306    306       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P62137}.
FT   MOD_RES     320    320       Phosphothreonine.
FT                                {ECO:0000269|PubMed:16732323,
FT                                ECO:0000269|PubMed:18088087,
FT                                ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:20068231}.
FT   VAR_SEQ      18     18       E -> EGSRVLTPHCAP (in isoform 2).
FT                                {ECO:0000303|PubMed:8384581}.
FT                                /FTId=VSP_043377.
FT   VAR_SEQ      19     62       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_046754.
FT   HELIX         9     18       {ECO:0000244|PDB:4MOV}.
FT   TURN         19     21       {ECO:0000244|PDB:4MOV}.
FT   HELIX        32     48       {ECO:0000244|PDB:4MOV}.
FT   STRAND       51     55       {ECO:0000244|PDB:4MOV}.
FT   STRAND       57     62       {ECO:0000244|PDB:4MOV}.
FT   HELIX        69     79       {ECO:0000244|PDB:4MOV}.
FT   STRAND       87     89       {ECO:0000244|PDB:4MOV}.
FT   STRAND       94     98       {ECO:0000244|PDB:4MOV}.
FT   HELIX       100    113       {ECO:0000244|PDB:4MOV}.
FT   TURN        115    117       {ECO:0000244|PDB:4MOV}.
FT   STRAND      118    120       {ECO:0000244|PDB:4MOV}.
FT   HELIX       128    134       {ECO:0000244|PDB:4MOV}.
FT   HELIX       136    143       {ECO:0000244|PDB:4MOV}.
FT   HELIX       146    156       {ECO:0000244|PDB:4MOV}.
FT   STRAND      162    165       {ECO:0000244|PDB:4MOV}.
FT   TURN        166    168       {ECO:0000244|PDB:4MOV}.
FT   STRAND      169    171       {ECO:0000244|PDB:4MOV}.
FT   HELIX       184    187       {ECO:0000244|PDB:4MOV}.
FT   STRAND      197    199       {ECO:0000244|PDB:4MOV}.
FT   HELIX       200    206       {ECO:0000244|PDB:4MOV}.
FT   STRAND      214    218       {ECO:0000244|PDB:4MOV}.
FT   STRAND      222    227       {ECO:0000244|PDB:4MOV}.
FT   HELIX       229    239       {ECO:0000244|PDB:4MOV}.
FT   STRAND      242    246       {ECO:0000244|PDB:4MOV}.
FT   STRAND      254    258       {ECO:0000244|PDB:4MOV}.
FT   TURN        259    262       {ECO:0000244|PDB:4MOV}.
FT   STRAND      263    267       {ECO:0000244|PDB:4MOV}.
FT   HELIX       272    274       {ECO:0000244|PDB:4MOV}.
FT   STRAND      280    285       {ECO:0000244|PDB:4MOV}.
FT   STRAND      291    296       {ECO:0000244|PDB:4MOV}.
SQ   SEQUENCE   330 AA;  37512 MW;  60C37E1AD9831DAC CRC64;
     MSDSEKLNLD SIIGRLLEVQ GSRPGKNVQL TENEIRGLCL KSREIFLSQP ILLELEAPLK
     ICGDIHGQYY DLLRLFEYGG FPPESNYLFL GDYVDRGKQS LETICLLLAY KIKYPENFFL
     LRGNHECASI NRIYGFYDEC KRRYNIKLWK TFTDCFNCLP IAAIVDEKIF CCHGGLSPDL
     QSMEQIRRIM RPTDVPDQGL LCDLLWSDPD KDVQGWGEND RGVSFTFGAE VVAKFLHKHD
     LDLICRAHQV VEDGYEFFAK RQLVTLFSAP NYCGEFDNAG AMMSVDETLM CSFQILKPAD
     KNKGKYGQFS GLNPGGRPIT PPRNSAKAKK
//
ID   PP1A_RABIT              Reviewed;         330 AA.
AC   P62139; P08128; P08129; P20653; P22802;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2004, sequence version 1.
DT   22-JUL-2015, entry version 104.
DE   RecName: Full=Serine/threonine-protein phosphatase PP1-alpha catalytic subunit;
DE            Short=PP-1A;
DE            EC=3.1.3.16;
GN   Name=PPP1CA; Synonyms=PPP1A;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=New Zealand white; TISSUE=Skeletal muscle;
RX   PubMed=2822491; DOI=10.1016/0014-5793(87)80316-2;
RA   Berndt N., Campbell D.G., Caudwell F.B., Cohen P.,
RA   da Cruz e Silva E.F., da Cruz e Silva O.B., Cohen P.T.W.;
RT   "Isolation and sequence analysis of a cDNA clone encoding a type-1
RT   protein phosphatase catalytic subunit: homology with protein
RT   phosphatase 2A.";
RL   FEBS Lett. 223:340-346(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Muscle;
RX   PubMed=2846396;
RA   Bai G., Zhang Z., Amin J., Deans-Zirattu S.A., Lee E.Y.C.;
RT   "Molecular cloning of a cDNA for the catalytic subunit of rabbit
RT   muscle phosphorylase phosphatase.";
RL   FASEB J. 2:3010-3016(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=New Zealand white; TISSUE=Skeletal muscle;
RX   PubMed=2835264; DOI=10.1016/0014-5793(88)80378-8;
RA   Cohen P.T.W.;
RT   "Two isoforms of protein phosphatase 1 may be produced from the same
RT   gene.";
RL   FEBS Lett. 232:17-23(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=New Zealand white; TISSUE=Liver;
RX   PubMed=2541784; DOI=10.1016/0167-4781(89)90181-4;
RA   Cohen P.T.W., Schelling D.L., da Cruz e Silva O.B., Barker H.M.,
RA   Cohen P.;
RT   "The major type-1 protein phosphatase catalytic subunits are the same
RT   gene products in rabbit skeletal muscle and rabbit liver.";
RL   Biochim. Biophys. Acta 1008:125-128(1989).
RN   [5]
RP   INTERACTION WITH PPP1R39.
RX   PubMed=19945436; DOI=10.1016/j.bbrc.2009.11.123;
RA   Chen C.Y., Lai N.S., Yang J.J., Huang H.L., Hung W.C., Li C.,
RA   Lin T.H., Huang H.B.;
RT   "FLJ23654 encodes a heart protein phosphatase 1-binding protein
RT   (Hepp1).";
RL   Biochem. Biophys. Res. Commun. 391:698-702(2010).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS,
RP   AND COFACTOR.
RX   PubMed=7651533; DOI=10.1038/376745a0;
RA   Goldberg J., Huang H.B., Kwon Y.G., Greengard P., Nairn A.C.,
RA   Kuriyan J.;
RT   "Three-dimensional structure of the catalytic subunit of protein
RT   serine/threonine phosphatase-1.";
RL   Nature 376:745-753(1995).
CC   -!- FUNCTION: Protein phosphatase that associates with over 200
CC       regulatory proteins to form highly specific holoenzymes which
CC       dephosphorylate hundreds of biological targets. Protein
CC       phosphatase 1 (PP1) is essential for cell division, and
CC       participates in the regulation of glycogen metabolism, muscle
CC       contractility and protein synthesis. Involved in regulation of
CC       ionic conductances and long-term synaptic plasticity. May play an
CC       important role in dephosphorylating substrates such as the
CC       postsynaptic density-associated Ca(2+)/calmodulin dependent
CC       protein kinase II. Component of the PTW/PP1 phosphatase complex,
CC       which plays a role in the control of chromatin structure and cell
CC       cycle progression during the transition from mitosis into
CC       interphase. Regulates NEK2 function in terms of kinase activity
CC       and centrosome number and splitting, both in the presence and
CC       absence of radiation-induced DNA damage. Regulator of neural tube
CC       and optic fissure closure, and enteric neural crest cell (ENCCs)
CC       migration during development. In balance with CSNK1D and CSNK1E,
CC       determines the circadian period length, through the regulation of
CC       the speed and rhythmicity of PER1 and PER2 phosphorylation. May
CC       dephosphorylate CSNK1D and CSNK1E (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:7651533};
CC       Note=Binds 2 manganese ions per subunit.
CC       {ECO:0000269|PubMed:7651533};
CC   -!- SUBUNIT: PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or
CC       PPP1CC, which is folded into its native form by inhibitor 2 and
CC       glycogen synthetase kinase 3, and then complexed to one or several
CC       targeting or regulatory subunits. PPP1R12A, PPP1R12B and PPP1R12C
CC       mediate binding to myosin. PPP1R3A (in skeletal muscle), PPP1R3B
CC       (in liver), PPP1R3C, PPP1R3D and PPP1R3F (in brain) mediate
CC       binding to glycogen. Interacts with PPP1R15A and PPP1R15B; the
CC       interactions mediate binding to EIF2S1. Part of a complex
CC       containing PPP1R15B, PP1 and NCK1/2. Component of the MLL5-L
CC       complex, at least composed of KMT2E/MLL5, STK38, PPP1CA, PPP1CB,
CC       PPP1CC, HCFC1, ACTB and OGT. Interacts with PPP1R9A, PPP1R9B and
CC       PPP1R7. Interacts with YLPM1. Forms a complex with ILF2, ILF3,
CC       YLPM1, KHDRBS1, RBMX and NCOA5. Interacts with NOM1 and PPP1R8.
CC       Interacts with PPP1R16B. Interacts with RPSA only in the presence
CC       of PPP1R16B. Component of the PTW/PP1 phosphatase complex,
CC       composed of PPP1R10/PNUTS, TOX4, WDR82, and PPP1CA or PPP1CB or
CC       PPP1CC. Interacts with PPP1R10/PNUTS and PPP1R8. Interacts with
CC       WDR82 in the presence of PPP1R10/PNUTS. Interacts with TRIM28; the
CC       interaction dephosphorylates TRIM28 on 'Ser-824' and forms a
CC       complex at the p21 promoter site (By similarity). Interacts with
CC       PPP1R39. Interacts with NEK2. Interacts with PHACTR4; which acts
CC       as an activator of PP1 activity. Interacts with FER; this promotes
CC       phosphorylation at Thr-320 (By similarity). Interacts with BTBD10
CC       (By similarity). Interacts with KCTD20 (By similarity). Interacts
CC       with FOXP3 (By similarity). {ECO:0000250|UniProtKB:P62136,
CC       ECO:0000250|UniProtKB:P62137, ECO:0000269|PubMed:19945436}.
CC   -!- INTERACTION:
CC       Q13224:GRIN2B (xeno); NbExp=2; IntAct=EBI-2008988, EBI-2256942;
CC       O60927:PPP1R11 (xeno); NbExp=2; IntAct=EBI-2008988, EBI-1048104;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus,
CC       nucleolus {ECO:0000250}. Note=Primarily nuclear and largely
CC       excluded from the nucleolus. Highly mobile in cells and can be
CC       relocalized through interaction with targeting subunits. NOM1
CC       plays a role in targeting this protein to the nucleolus. In the
CC       presence of PPP1R8 relocalizes from the nucleus to nuclear
CC       speckles (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2; Synonyms=1-alpha-2;
CC         IsoId=P62139-1, P08129-1;
CC         Sequence=Displayed;
CC       Name=1; Synonyms=1-alpha-1;
CC         IsoId=P62139-2, P08128-1;
CC         Sequence=VSP_010642;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in skeletal muscle (at protein
CC       level). Detected in skeletal muscle. {ECO:0000269|PubMed:2822491}.
CC   -!- PTM: Phosphorylated. Dephosphorylated at Thr-320 in the presence
CC       of ionizing radiation (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The things we forget -
CC       Issue 32 of March 2003;
CC       URL="http://web.expasy.org/spotlight/back_issues/032";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00701; CAA68693.1; -; mRNA.
DR   EMBL; X07798; CAA30645.1; -; mRNA.
DR   EMBL; X14832; CAA32941.1; -; mRNA.
DR   PIR; S04335; PARB11.
DR   RefSeq; NP_001095176.1; NM_001101706.1.
DR   UniGene; Ocu.2075; -.
DR   PDB; 1FJM; X-ray; 2.10 A; A/B=1-330.
DR   PDBsum; 1FJM; -.
DR   ProteinModelPortal; P62139; -.
DR   SMR; P62139; 7-299.
DR   BioGrid; 1172319; 79.
DR   IntAct; P62139; 3.
DR   MINT; MINT-106725; -.
DR   BindingDB; P62139; -.
DR   PRIDE; P62139; -.
DR   GeneID; 100009298; -.
DR   KEGG; ocu:100009298; -.
DR   CTD; 5499; -.
DR   eggNOG; COG0639; -.
DR   HOVERGEN; HBG000216; -.
DR   InParanoid; P62139; -.
DR   KO; K06269; -.
DR   EvolutionaryTrace; P62139; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0000164; C:protein phosphatase type 1 complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0072357; C:PTW/PP1 phosphatase complex; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016791; F:phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0070262; P:peptidyl-serine dephosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0036496; P:regulation of translational initiation by eIF2 alpha dephosphorylation; IDA:ParkinsonsUK-UCL.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_apaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Biological rhythms;
KW   Carbohydrate metabolism; Cell cycle; Cell division; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Glycogen metabolism; Hydrolase;
KW   Manganese; Metal-binding; Nucleus; Phosphoprotein;
KW   Protein phosphatase; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P62136}.
FT   CHAIN         2    330       Serine/threonine-protein phosphatase PP1-
FT                                alpha catalytic subunit.
FT                                /FTId=PRO_0000058776.
FT   ACT_SITE    125    125       Proton donor. {ECO:0000250}.
FT   METAL        64     64       Manganese 1.
FT   METAL        66     66       Manganese 1.
FT   METAL        92     92       Manganese 1.
FT   METAL        92     92       Manganese 2.
FT   METAL       124    124       Manganese 2.
FT   METAL       173    173       Manganese 2.
FT   METAL       248    248       Manganese 2.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000250|UniProtKB:P62136}.
FT   MOD_RES     305    305       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P62137}.
FT   MOD_RES     306    306       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P62137}.
FT   MOD_RES     320    320       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P62136}.
FT   VAR_SEQ       1     33       MSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTEN -> MVTI
FT                                MTTSEYLSGY (in isoform 1).
FT                                {ECO:0000303|PubMed:2822491}.
FT                                /FTId=VSP_010642.
FT   CONFLICT    309    309       F -> L (in Ref. 1; CAA68693 and 3;
FT                                CAA30645). {ECO:0000305}.
FT   HELIX         9     18       {ECO:0000244|PDB:1FJM}.
FT   TURN         19     22       {ECO:0000244|PDB:1FJM}.
FT   HELIX        32     48       {ECO:0000244|PDB:1FJM}.
FT   STRAND       51     55       {ECO:0000244|PDB:1FJM}.
FT   STRAND       57     62       {ECO:0000244|PDB:1FJM}.
FT   HELIX        69     79       {ECO:0000244|PDB:1FJM}.
FT   STRAND       87     89       {ECO:0000244|PDB:1FJM}.
FT   STRAND       94     98       {ECO:0000244|PDB:1FJM}.
FT   HELIX       100    113       {ECO:0000244|PDB:1FJM}.
FT   TURN        115    117       {ECO:0000244|PDB:1FJM}.
FT   STRAND      118    120       {ECO:0000244|PDB:1FJM}.
FT   HELIX       128    134       {ECO:0000244|PDB:1FJM}.
FT   HELIX       136    143       {ECO:0000244|PDB:1FJM}.
FT   HELIX       146    156       {ECO:0000244|PDB:1FJM}.
FT   STRAND      162    165       {ECO:0000244|PDB:1FJM}.
FT   TURN        166    168       {ECO:0000244|PDB:1FJM}.
FT   STRAND      169    174       {ECO:0000244|PDB:1FJM}.
FT   HELIX       183    188       {ECO:0000244|PDB:1FJM}.
FT   STRAND      197    199       {ECO:0000244|PDB:1FJM}.
FT   HELIX       200    206       {ECO:0000244|PDB:1FJM}.
FT   STRAND      214    218       {ECO:0000244|PDB:1FJM}.
FT   STRAND      222    227       {ECO:0000244|PDB:1FJM}.
FT   HELIX       229    239       {ECO:0000244|PDB:1FJM}.
FT   STRAND      242    246       {ECO:0000244|PDB:1FJM}.
FT   STRAND      254    258       {ECO:0000244|PDB:1FJM}.
FT   TURN        259    262       {ECO:0000244|PDB:1FJM}.
FT   STRAND      263    267       {ECO:0000244|PDB:1FJM}.
FT   STRAND      274    276       {ECO:0000244|PDB:1FJM}.
FT   STRAND      280    285       {ECO:0000244|PDB:1FJM}.
FT   STRAND      291    296       {ECO:0000244|PDB:1FJM}.
SQ   SEQUENCE   330 AA;  37512 MW;  60C37E1AD9831DAC CRC64;
     MSDSEKLNLD SIIGRLLEVQ GSRPGKNVQL TENEIRGLCL KSREIFLSQP ILLELEAPLK
     ICGDIHGQYY DLLRLFEYGG FPPESNYLFL GDYVDRGKQS LETICLLLAY KIKYPENFFL
     LRGNHECASI NRIYGFYDEC KRRYNIKLWK TFTDCFNCLP IAAIVDEKIF CCHGGLSPDL
     QSMEQIRRIM RPTDVPDQGL LCDLLWSDPD KDVQGWGEND RGVSFTFGAE VVAKFLHKHD
     LDLICRAHQV VEDGYEFFAK RQLVTLFSAP NYCGEFDNAG AMMSVDETLM CSFQILKPAD
     KNKGKYGQFS GLNPGGRPIT PPRNSAKAKK
//
ID   PP1A_RAT                Reviewed;         330 AA.
AC   P62138; P08129; P20653; P22802;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2004, sequence version 1.
DT   22-JUL-2015, entry version 109.
DE   RecName: Full=Serine/threonine-protein phosphatase PP1-alpha catalytic subunit;
DE            Short=PP-1A;
DE            EC=3.1.3.16;
GN   Name=Ppp1ca; Synonyms=Ppp1a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=1650776;
RA   Kitamura K., Mizuno Y., Sasaki A., Yasui A., Tsuiki S., Kikuchi K.;
RT   "Molecular cloning and sequence analysis of cDNA for the catalytic
RT   subunit 1 alpha of rat kidney type 1 protein phosphatase, and
RT   detection of the gene expression at high levels in hepatoma cells and
RT   regenerating livers as compared to rat livers.";
RL   J. Biochem. 109:307-310(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2177460;
RA   Sasaki K., Shima H., Kitagawa Y., Irino S., Sugimura T., Nagao M.;
RT   "Identification of members of the protein phosphatase 1 gene family in
RT   the rat and enhanced expression of protein phosphatase 1 alpha gene in
RT   rat hepatocellular carcinomas.";
RL   Jpn. J. Cancer Res. 81:1272-1280(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7751917;
RA   da Cruz e Silva E.F., Fox C.A., Ouimet C.C., Gustafson E.,
RA   Watson S.J., Greengard P.;
RT   "Differential expression of protein phosphatase 1 isoforms in
RT   mammalian brain.";
RL   J. Neurosci. 15:3375-3389(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 7-26 AND 212-234, AND INTERACTION WITH PPP1R9A AND
RP   PPP1R9B.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10504266; DOI=10.1021/bi991227d;
RA   McAvoy T., Allen P.B., Obaishi H., Nakanishi H., Takai Y.,
RA   Greengard P., Nairn A.C., Hemmings H.C. Jr.;
RT   "Regulation of neurabin I interaction with protein phosphatase 1 by
RT   phosphorylation.";
RL   Biochemistry 38:12943-12949(1999).
RN   [6]
RP   PROTEIN SEQUENCE OF 44-60 AND 112-122, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [7]
RP   INTERACTION WITH YLPM1.
RX   PubMed=17890166; DOI=10.1016/j.bbapap.2007.07.015;
RA   Ulke-Lemee A., Trinkle-Mulcahy L., Chaulk S., Bernstein N.K.,
RA   Morrice N., Glover M., Lamond A.I., Moorhead G.B.G.;
RT   "The nuclear PP1 interacting protein ZAP3 (ZAP) is a putative
RT   nucleoside kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-
RT   G.";
RL   Biochim. Biophys. Acta 1774:1339-1350(2007).
CC   -!- FUNCTION: Protein phosphatase that associates with over 200
CC       regulatory proteins to form highly specific holoenzymes which
CC       dephosphorylate hundreds of biological targets. Protein
CC       phosphatase 1 (PP1) is essential for cell division, and
CC       participates in the regulation of glycogen metabolism, muscle
CC       contractility and protein synthesis. Involved in regulation of
CC       ionic conductances and long-term synaptic plasticity. May play an
CC       important role in dephosphorylating substrates such as the
CC       postsynaptic density-associated Ca(2+)/calmodulin dependent
CC       protein kinase II. Component of the PTW/PP1 phosphatase complex,
CC       which plays a role in the control of chromatin structure and cell
CC       cycle progression during the transition from mitosis into
CC       interphase. Regulates NEK2 function in terms of kinase activity
CC       and centrosome number and splitting, both in the presence and
CC       absence of radiation-induced DNA damage. Regulator of neural tube
CC       and optic fissure closure, and enteric neural crest cell (ENCCs)
CC       migration during development. In balance with CSNK1D and CSNK1E,
CC       determines the circadian period length, through the regulation of
CC       the speed and rhythmicity of PER1 and PER2 phosphorylation. May
CC       dephosphorylate CSNK1D and CSNK1E (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Binds 2 manganese ions per subunit. {ECO:0000250};
CC   -!- SUBUNIT: PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or
CC       PPP1CC, which is folded into its native form by inhibitor 2 and
CC       glycogen synthetase kinase 3, and then complexed to one or several
CC       targeting or regulatory subunits. PPP1R12A, PPP1R12B and PPP1R12C
CC       mediate binding to myosin. PPP1R3A (in skeletal muscle), PPP1R3B
CC       (in liver), PPP1R3C, PPP1R3D and PPP1R3F (in brain) mediate
CC       binding to glycogen. Interacts with PPP1R15A and PPP1R15B; the
CC       interactions mediate binding to EIF2S1. Part of a complex
CC       containing PPP1R15B, PP1 and NCK1/2. Component of the MLL5-L
CC       complex, at least composed of KMT2E/MLL5, STK38, PPP1CA, PPP1CB,
CC       PPP1CC, HCFC1, ACTB and OGT. Interacts with PPP1R7. Forms a
CC       complex with ILF2, ILF3, YLPM1, KHDRBS1, RBMX and NCOA5. Interacts
CC       with NOM1 and PPP1R8. Interacts with PPP1R16B. Interacts with RPSA
CC       only in the presence of PPP1R16B. Component of the PTW/PP1
CC       phosphatase complex, composed of PPP1R10/PNUTS, TOX4, WDR82, and
CC       PPP1CA or PPP1CB or PPP1CC. Interacts with PPP1R10/PNUTS and
CC       PPP1R8. Interacts with WDR82 in the presence of PPP1R10/PNUTS.
CC       Interacts with PPP1R39. Interacts with TRIM28; the interaction
CC       dephosphorylates TRIM28 on 'Ser-824' and forms a complex at the
CC       p21 promoter site (By similarity). Interacts with PPP1R9A, PPP1R9B
CC       and YLPM1. Interacts with NEK2. Interacts with PHACTR4; which acts
CC       as an activator of PP1 activity. Interacts with FER; this promotes
CC       phosphorylation at Thr-320 (By similarity). Interacts with BTBD10
CC       (By similarity). Interacts with KCTD20 (By similarity). Interacts
CC       with FOXP3 (By similarity). {ECO:0000250|UniProtKB:P62136,
CC       ECO:0000250|UniProtKB:P62137, ECO:0000250|UniProtKB:P62139,
CC       ECO:0000269|PubMed:17890166}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus,
CC       nucleolus {ECO:0000250}. Note=Primarily nuclear and largely
CC       excluded from the nucleolus. Highly mobile in cells and can be
CC       relocalized through interaction with targeting subunits. NOM1
CC       plays a role in targeting it to the nucleolus. In the presence of
CC       PPP1R8 relocalizes from the nucleus to nuclear speckles (By
CC       similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:7751917}.
CC   -!- PTM: Phosphorylated. Dephosphorylated at Thr-320 in the presence
CC       of ionizing radiation (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The things we forget -
CC       Issue 32 of March 2003;
CC       URL="http://web.expasy.org/spotlight/back_issues/032";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D00859; BAA00732.1; -; mRNA.
DR   EMBL; D90163; BAA14194.1; -; mRNA.
DR   EMBL; BC070517; AAH70517.1; -; mRNA.
DR   PIR; JX0157; JX0157.
DR   RefSeq; NP_113715.1; NM_031527.1.
DR   UniGene; Rn.2024; -.
DR   ProteinModelPortal; P62138; -.
DR   SMR; P62138; 7-299.
DR   BioGrid; 246800; 2.
DR   IntAct; P62138; 1.
DR   STRING; 10116.ENSRNOP00000025282; -.
DR   BindingDB; P62138; -.
DR   PhosphoSite; P62138; -.
DR   PaxDb; P62138; -.
DR   PRIDE; P62138; -.
DR   Ensembl; ENSRNOT00000025282; ENSRNOP00000025282; ENSRNOG00000018708.
DR   GeneID; 24668; -.
DR   KEGG; rno:24668; -.
DR   UCSC; RGD:3375; rat.
DR   CTD; 5499; -.
DR   RGD; 3375; Ppp1ca.
DR   eggNOG; COG0639; -.
DR   GeneTree; ENSGT00530000062911; -.
DR   HOGENOM; HOG000172697; -.
DR   HOVERGEN; HBG000216; -.
DR   InParanoid; P62138; -.
DR   KO; K06269; -.
DR   OMA; QGLETIC; -.
DR   OrthoDB; EOG7TJ3K3; -.
DR   PhylomeDB; P62138; -.
DR   TreeFam; TF354243; -.
DR   Reactome; REACT_323337; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; REACT_336534; Downregulation of TGF-beta receptor signaling.
DR   Reactome; REACT_347255; Circadian Clock.
DR   Reactome; REACT_348359; DARPP-32 events.
DR   NextBio; 604034; -.
DR   PRO; PR:P62138; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   ExpressionAtlas; P62138; baseline.
DR   Genevisible; P62138; RN.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0042587; C:glycogen granule; IDA:RGD.
DR   GO; GO:0070688; C:MLL5-L complex; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0000164; C:protein phosphatase type 1 complex; IDA:RGD.
DR   GO; GO:0072357; C:PTW/PP1 phosphatase complex; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016791; F:phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:RGD.
DR   GO; GO:0032403; F:protein complex binding; IPI:RGD.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IPI:RGD.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IPI:RGD.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:RGD.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0005979; P:regulation of glycogen biosynthetic process; IDA:RGD.
DR   GO; GO:0005981; P:regulation of glycogen catabolic process; IDA:RGD.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_apaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Biological rhythms; Carbohydrate metabolism; Cell cycle;
KW   Cell division; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Glycogen metabolism; Hydrolase; Manganese;
KW   Metal-binding; Nucleus; Phosphoprotein; Protein phosphatase;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P62136}.
FT   CHAIN         2    330       Serine/threonine-protein phosphatase PP1-
FT                                alpha catalytic subunit.
FT                                /FTId=PRO_0000058777.
FT   ACT_SITE    125    125       Proton donor. {ECO:0000250}.
FT   METAL        64     64       Manganese 1. {ECO:0000250}.
FT   METAL        66     66       Manganese 1. {ECO:0000250}.
FT   METAL        92     92       Manganese 1. {ECO:0000250}.
FT   METAL        92     92       Manganese 2. {ECO:0000250}.
FT   METAL       124    124       Manganese 2. {ECO:0000250}.
FT   METAL       173    173       Manganese 2. {ECO:0000250}.
FT   METAL       248    248       Manganese 2. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000250|UniProtKB:P62136}.
FT   MOD_RES     305    305       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P62137}.
FT   MOD_RES     306    306       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P62137}.
FT   MOD_RES     320    320       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P62136}.
SQ   SEQUENCE   330 AA;  37512 MW;  60C37E1AD9831DAC CRC64;
     MSDSEKLNLD SIIGRLLEVQ GSRPGKNVQL TENEIRGLCL KSREIFLSQP ILLELEAPLK
     ICGDIHGQYY DLLRLFEYGG FPPESNYLFL GDYVDRGKQS LETICLLLAY KIKYPENFFL
     LRGNHECASI NRIYGFYDEC KRRYNIKLWK TFTDCFNCLP IAAIVDEKIF CCHGGLSPDL
     QSMEQIRRIM RPTDVPDQGL LCDLLWSDPD KDVQGWGEND RGVSFTFGAE VVAKFLHKHD
     LDLICRAHQV VEDGYEFFAK RQLVTLFSAP NYCGEFDNAG AMMSVDETLM CSFQILKPAD
     KNKGKYGQFS GLNPGGRPIT PPRNSAKAKK
//
ID   PP1A_MOUSE              Reviewed;         330 AA.
AC   P62137; P08129; P20653; P22802; Q3U7G7; Q9Z1G2;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2004, sequence version 1.
DT   22-JUL-2015, entry version 121.
DE   RecName: Full=Serine/threonine-protein phosphatase PP1-alpha catalytic subunit;
DE            Short=PP-1A;
DE            EC=3.1.3.16;
GN   Name=Ppp1ca; Synonyms=Ppp1a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Ortiz J.M., Lorenzo M.L., Eguiraun A., Andres I., Sangrador A.,
RA   Allshire R., Hastie N.D.;
RL   Submitted (APR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and DBA/2;
RC   TISSUE=Extraembryonic tissue, Liver, Pancreas, and Placenta;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 44-74; 114-122 AND 247-260, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Hippocampus;
RA   Lubec G., Klug S.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 69-90.
RX   PubMed=8077208;
RA   Becker W., Kentrup H., Klumpp S., Schultz J.E., Joost H.G.;
RT   "Molecular cloning of a protein serine/threonine phosphatase
RT   containing a putative regulatory tetratricopeptide repeat domain.";
RL   J. Biol. Chem. 269:22586-22592(1994).
RN   [6]
RP   INTERACTION WITH PPP1R15B.
RX   PubMed=14638860; DOI=10.1083/jcb.200308075;
RA   Jousse C., Oyadomari S., Novoa I., Lu P., Zhang Y., Harding H.P.,
RA   Ron D.;
RT   "Inhibition of a constitutive translation initiation factor 2alpha
RT   phosphatase, CReP, promotes survival of stressed cells.";
RL   J. Cell Biol. 163:767-775(2003).
RN   [7]
RP   IDENTIFICATION IN COMPLEX WITH PPP1R15B AND NCK1.
RX   PubMed=16835242; DOI=10.1074/jbc.M513556200;
RA   Latreille M., Larose L.;
RT   "Nck in a complex containing the catalytic subunit of protein
RT   phosphatase 1 regulates eukaryotic initiation factor 2alpha signaling
RT   and cell survival to endoplasmic reticulum stress.";
RL   J. Biol. Chem. 281:26633-26644(2006).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH PHACTR4.
RX   PubMed=17609112; DOI=10.1016/j.devcel.2007.04.018;
RA   Kim T.H., Goodman J., Anderson K.V., Niswander L.;
RT   "Phactr4 regulates neural tube and optic fissure closure by
RT   controlling PP1-, Rb-, and E2F1-regulated cell-cycle progression.";
RL   Dev. Cell 13:87-102(2007).
RN   [9]
RP   INTERACTION WITH BTBD10.
RX   PubMed=18160256; DOI=10.1016/j.cellsig.2007.11.004;
RA   Nawa M., Kanekura K., Hashimoto Y., Aiso S., Matsuoka M.;
RT   "A novel Akt/PKB-interacting protein promotes cell adhesion and
RT   inhibits familial amyotrophic lateral sclerosis-linked mutant SOD1-
RT   induced neuronal death via inhibition of PP2A-mediated
RT   dephosphorylation of Akt/PKB.";
RL   Cell. Signal. 20:493-505(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-306, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=19131326; DOI=10.1074/mcp.M800451-MCP200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of
RT   electron capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [11]
RP   FUNCTION IN CIRCADIAN CLOCK.
RX   PubMed=21712997; DOI=10.1371/journal.pone.0021325;
RA   Schmutz I., Wendt S., Schnell A., Kramer A., Mansuy I.M., Albrecht U.;
RT   "Protein phosphatase 1 (PP1) is a post-translational regulator of the
RT   mammalian circadian clock.";
RL   PLoS ONE 6:E21325-E21325(2011).
RN   [12]
RP   FUNCTION IN CIRCADIAN CLOCK, AND MUTAGENESIS OF ASP-64 AND ASP-95.
RX   PubMed=21930935; DOI=10.1073/pnas.1107178108;
RA   Lee H.M., Chen R., Kim H., Etchegaray J.P., Weaver D.R., Lee C.;
RT   "The period of the circadian oscillator is primarily determined by the
RT   balance between casein kinase 1 and protein phosphatase 1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:16451-16456(2011).
RN   [13]
RP   FUNCTION.
RX   PubMed=22215812; DOI=10.1101/gad.179283.111;
RA   Zhang Y., Kim T.H., Niswander L.;
RT   "Phactr4 regulates directional migration of enteric neural crest
RT   through PP1, integrin signaling, and cofilin activity.";
RL   Genes Dev. 26:69-81(2012).
RN   [14]
RP   INTERACTION WITH KCTD20.
RX   PubMed=24156551; DOI=10.1186/1471-2091-14-27;
RA   Nawa M., Matsuoka M.;
RT   "KCTD20, a relative of BTBD10, is a positive regulator of Akt.";
RL   BMC Biochem. 14:27-27(2013).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-305, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z.,
RA   Zhang Y., Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
CC   -!- FUNCTION: Protein phosphatase that associates with over 200
CC       regulatory proteins to form highly specific holoenzymes which
CC       dephosphorylate hundreds of biological targets. Protein
CC       phosphatase 1 (PP1) is essential for cell division, and
CC       participates in the regulation of glycogen metabolism, muscle
CC       contractility and protein synthesis. Involved in regulation of
CC       ionic conductances and long-term synaptic plasticity. May play an
CC       important role in dephosphorylating substrates such as the
CC       postsynaptic density-associated Ca(2+)/calmodulin dependent
CC       protein kinase II. Component of the PTW/PP1 phosphatase complex,
CC       which plays a role in the control of chromatin structure and cell
CC       cycle progression during the transition from mitosis into
CC       interphase. Regulates NEK2 function in terms of kinase activity
CC       and centrosome number and splitting, both in the presence and
CC       absence of radiation-induced DNA damage. Regulator of neural tube
CC       and optic fissure closure, and enteric neural crest cell (ENCCs)
CC       migration during development. In balance with CSNK1D and CSNK1E,
CC       determines the circadian period length, through the regulation of
CC       the speed and rhythmicity of PER1 and PER2 phosphorylation. May
CC       dephosphorylate CSNK1D and CSNK1E. {ECO:0000269|PubMed:17609112,
CC       ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:21930935,
CC       ECO:0000269|PubMed:22215812}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000250};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Binds 2 manganese ions per subunit. {ECO:0000250};
CC   -!- SUBUNIT: PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or
CC       PPP1CC, which is folded into its native form by inhibitor 2 and
CC       glycogen synthetase kinase 3, and then complexed to one or several
CC       targeting or regulatory subunits. PPP1R12A, PPP1R12B and PPP1R12C
CC       mediate binding to myosin. PPP1R3A (in skeletal muscle), PPP1R3B
CC       (in liver), PPP1R3C, PPP1R3D and PPP1R3F (in brain) mediate
CC       binding to glycogen. Component of the MLL5-L complex, at least
CC       composed of KMT2E/MLL5, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB
CC       and OGT. Interacts with PPP1R9A, PPP1R9B and PPP1R7. Interacts
CC       with PPP1R15A; the interaction mediates binding to EIF2S1.
CC       Interacts with YLPM1. Forms a complex with ILF2, ILF3, YLPM1,
CC       KHDRBS1, RBMX and NCOA5. Interacts with NOM1 and PPP1R8. Interacts
CC       with PPP1R16B. Interacts. with RPSA only in the presence of
CC       PPP1R16B. Component of the PTW/PP1 phosphatase complex, composed
CC       of PPP1R10/PNUTS, TOX4, WDR82, and PPP1CA or PPP1CB or PPP1CC.
CC       Interacts with PPP1R10/PNUTS and PPP1R8. Interacts with WDR82 in
CC       the presence of PPP1R10/PNUTS. Interacts with PPP1R39. Interacts
CC       with TRIM28; the interaction dephosphorylates TRIM28 on 'Ser-824'
CC       and forms a complex at the p21 promoter site (By similarity).
CC       Interacts with PPP1R15B; the interaction mediates binding to
CC       EIF2S1. Part of a complex containing PPP1R15B, PP1 and NCK1/2.
CC       Interacts with NEK2. Interacts with FER; this promotes
CC       phosphorylation at Thr-320 (By similarity). Interacts with
CC       PHACTR4; which acts as an activator of PP1 activity. Interacts
CC       with BTBD10 (PubMed:18160256). Interacts with KCTD20
CC       (PubMed:24156551). Interacts with FOXP3 (By similarity).
CC       {ECO:0000250|UniProtKB:P62136, ECO:0000250|UniProtKB:P62139,
CC       ECO:0000269|PubMed:14638860, ECO:0000269|PubMed:16835242,
CC       ECO:0000269|PubMed:17609112, ECO:0000269|PubMed:18160256,
CC       ECO:0000269|PubMed:24156551}.
CC   -!- INTERACTION:
CC       Q9WTL8:Arntl; NbExp=2; IntAct=EBI-357187, EBI-644534;
CC       O35625:Axin1; NbExp=2; IntAct=EBI-357187, EBI-2365912;
CC       P41136:Id2; NbExp=2; IntAct=EBI-357187, EBI-309167;
CC       P17918:Pcna; NbExp=2; IntAct=EBI-357187, EBI-1173716;
CC       Q9WTX5:Skp1; NbExp=2; IntAct=EBI-357187, EBI-1202363;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus,
CC       nucleolus {ECO:0000250}. Note=Primarily nuclear and largely
CC       excluded from the nucleolus. Highly mobile in cells and can be
CC       relocalized through interaction with targeting subunits. NOM1
CC       plays a role in targeting this protein to the nucleolus. In the
CC       presence of PPP1R8 relocalizes from the nucleus to nuclear
CC       speckles (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated. Dephosphorylated at Thr-320 in the presence
CC       of ionizing radiation (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The things we forget -
CC       Issue 32 of March 2003;
CC       URL="http://web.expasy.org/spotlight/back_issues/032";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U25809; AAC99814.1; -; mRNA.
DR   EMBL; AK007932; BAB25358.1; -; mRNA.
DR   EMBL; AK028392; BAC25928.1; -; mRNA.
DR   EMBL; AK090070; BAC41078.1; -; mRNA.
DR   EMBL; AK151582; BAE30522.1; -; mRNA.
DR   EMBL; AK152667; BAE31402.1; -; mRNA.
DR   EMBL; AK153517; BAE32060.1; -; mRNA.
DR   EMBL; AK159575; BAE35196.1; -; mRNA.
DR   EMBL; AK167244; BAE39365.1; -; mRNA.
DR   EMBL; AK167538; BAE39605.1; -; mRNA.
DR   EMBL; AK167880; BAE39893.1; -; mRNA.
DR   EMBL; AK167981; BAE39973.1; -; mRNA.
DR   EMBL; BC014828; AAH14828.1; -; mRNA.
DR   CCDS; CCDS29421.1; -.
DR   RefSeq; NP_114074.1; NM_031868.2.
DR   UniGene; Mm.1970; -.
DR   UniGene; Mm.474260; -.
DR   ProteinModelPortal; P62137; -.
DR   SMR; P62137; 7-299.
DR   BioGrid; 202335; 30.
DR   IntAct; P62137; 28.
DR   MINT; MINT-4108290; -.
DR   STRING; 10090.ENSMUSP00000039109; -.
DR   PhosphoSite; P62137; -.
DR   MaxQB; P62137; -.
DR   PaxDb; P62137; -.
DR   PRIDE; P62137; -.
DR   Ensembl; ENSMUST00000046094; ENSMUSP00000039109; ENSMUSG00000040385.
DR   Ensembl; ENSMUST00000180575; ENSMUSP00000137997; ENSMUSG00000096994.
DR   GeneID; 19045; -.
DR   KEGG; mmu:19045; -.
DR   UCSC; uc008fzg.1; mouse.
DR   CTD; 5499; -.
DR   MGI; MGI:103016; Ppp1ca.
DR   eggNOG; COG0639; -.
DR   GeneTree; ENSGT00530000062911; -.
DR   HOGENOM; HOG000172697; -.
DR   HOVERGEN; HBG000216; -.
DR   InParanoid; P62137; -.
DR   KO; K06269; -.
DR   OMA; QGLETIC; -.
DR   OrthoDB; EOG7TJ3K3; -.
DR   PhylomeDB; P62137; -.
DR   TreeFam; TF354243; -.
DR   Reactome; REACT_294789; Downregulation of TGF-beta receptor signaling.
DR   Reactome; REACT_316390; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; REACT_325290; DARPP-32 events.
DR   ChiTaRS; Ppp1ca; mouse.
DR   NextBio; 295505; -.
DR   PRO; PR:P62137; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   Proteomes; UP000000589; Unplaced.
DR   Bgee; P62137; -.
DR   Genevisible; P62137; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0042587; C:glycogen granule; IEA:Ensembl.
DR   GO; GO:0070688; C:MLL5-L complex; ISO:MGI.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0000164; C:protein phosphatase type 1 complex; IEA:Ensembl.
DR   GO; GO:0072357; C:PTW/PP1 phosphatase complex; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016791; F:phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:MGI.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:MGI.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IMP:MGI.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0009987; P:cellular process; TAS:MGI.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0016311; P:dephosphorylation; ISO:MGI.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; IMP:UniProtKB.
DR   GO; GO:0007143; P:female meiotic division; TAS:MGI.
DR   GO; GO:0005977; P:glycogen metabolic process; TAS:MGI.
DR   GO; GO:0030324; P:lung development; IMP:MGI.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:MGI.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IDA:UniProtKB.
DR   GO; GO:0005979; P:regulation of glycogen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0005981; P:regulation of glycogen catabolic process; IEA:Ensembl.
DR   GO; GO:0006417; P:regulation of translation; TAS:MGI.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_apaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Biological rhythms; Carbohydrate metabolism; Cell cycle;
KW   Cell division; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Glycogen metabolism; Hydrolase; Manganese;
KW   Metal-binding; Nucleus; Phosphoprotein; Protein phosphatase;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P62136}.
FT   CHAIN         2    330       Serine/threonine-protein phosphatase PP1-
FT                                alpha catalytic subunit.
FT                                /FTId=PRO_0000058775.
FT   ACT_SITE    125    125       Proton donor. {ECO:0000250}.
FT   METAL        64     64       Manganese 1. {ECO:0000250}.
FT   METAL        66     66       Manganese 1. {ECO:0000250}.
FT   METAL        92     92       Manganese 1. {ECO:0000250}.
FT   METAL        92     92       Manganese 2. {ECO:0000250}.
FT   METAL       124    124       Manganese 2. {ECO:0000250}.
FT   METAL       173    173       Manganese 2. {ECO:0000250}.
FT   METAL       248    248       Manganese 2. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000250|UniProtKB:P62136}.
FT   MOD_RES     305    305       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:23806337}.
FT   MOD_RES     306    306       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:19131326}.
FT   MOD_RES     320    320       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P62136}.
FT   MUTAGEN      64     64       D->N: Dominant negatif, severely disrupts
FT                                circadian rhythmicity of transcription.
FT                                {ECO:0000269|PubMed:21930935}.
FT   MUTAGEN      95     95       D->N: Dominant negatif, severely disrupts
FT                                circadian rhythmicity of transcription.
FT                                {ECO:0000269|PubMed:21930935}.
SQ   SEQUENCE   330 AA;  37540 MW;  8FBFD158A52282E0 CRC64;
     MSDSEKLNLD SIIGRLLEVQ GSRPGKNVQL TENEIRGLCL KSREIFLSQP ILLELEAPLK
     ICGDIHGQYY DLLRLFEYGG FPPESNYLFL GDYVDRGKQS LETICLLLAY KIRYPENFFL
     LRGNHECASI NRIYGFYDEC KRRYNIKLWK TFTDCFNCLP IAAIVDEKIF CCHGGLSPDL
     QSMEQIRRIM RPTDVPDQGL LCDLLWSDPD KDVQGWGEND RGVSFTFGAE VVAKFLHKHD
     LDLICRAHQV VEDGYEFFAK RQLVTLFSAP NYCGEFDNAG AMMSVDETLM CSFQILKPAD
     KNKGKYGQFS GLNPGGRPIT PPRNSAKAKK
//
